Skip to search formSkip to main contentSkip to account menu

Dihydroergocornine

Known as: Dihydroergocornine [Chemical/Ingredient], Ergocornine, 9,10-dihydro-, Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-2',5'alpha-bis(1-methylethyl)- 
A 9,10alpha-dihydro derivative of ERGOTAMINE that contains isopropyl sidechains at the 2' and 5' positions of the molecule.
National Institutes of Health

Related topics

Related topics

20 relations
AmprenavirAngina Pectoris, VariantCerebral Arterial Vasoconstriction [PE]Dihydroergotoxine

Narrower (1)

Dihydroergocornine Mesylate

Broader (1)

Dopamine Agonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Changes induced by aging and drug treatment on cerebral enzymatic antioxidant system
The age-related modifications of the participants to the cerebral enzymatic antioxidant system (superoxide dismutase, glutathione… 
1987
1987
Prolactin regulation of estrogen and progesterone receptors in normal and neoplastic mouse mammary tissue.
The transplantable mouse mammary tumor, TPDMT-4, is pregnancy-dependent and requires prolactin (PRL), estradiol (E2) and… 
1983
1983
Interaction of ergot alkaloids and their combination (co-dergocrine) with alpha-adrenoceptors in the CNS.
1982
1982
Dopamine receptor profile of co-dergocrine (Hydergine) and its components.
1978
1978
Dihydroergotoxine: separation and determination of four components by high-performance liquid chromatography.
The evaluation of a new high-performance liquid chromatographic method is described. It permits the separation and determination… 
1976
1976
Determination of dihydroergotoxine alkaloids by gas-liquid chromatography.
Highly Cited
1974
Highly Cited
1974
Inhibition of prolactin secretion by ergolines.
Peptide-containing ergot alkaloids and synthetic ergoline derivatives were administered to reserpine-treated male rats in order… 
Highly Cited
1972
Highly Cited
1972
Inhibition of lactation and prolactin secretion in rats by ergot alkaloids.
Ergocornine hydrogenmalienate, 0.5 mg and 1.0 mg; ergonovine maleate, 4.0 mg; dihydroergocornine, 1.0 mg; ergotamine tartrate, 4… 
1949
1949
Effect of Dihydroergocornine on the Heart.∗
Summary The intravenous administration of 0.5 mg of dihydroergocornine to 24 patients with left ventricular hypertrophy caused no… 
Highly Cited
1948
Highly Cited
1948
The effect of ergot derivatives on the circulation in man with special reference to two new hydrogenated compounds, dihydroergotamine and dihydroergocornine.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)